Subscribe To
Merck's keytruda shows positive results in confirmatory trial as treatment for rare form of esophageal cancer
Merck & Co. MRK, -1.53% said Friday a late-stage trial of its blockbuster cancer drug Keytruda plus trastuzumab, fluoropyrimidine- and platinum-contai...
October 20, 2023, 8:13 am
Enphase energy: avoid ahead of anticipated weak results and outlook
After the close of Wednesday's regular session, Enphase Energy's main competitor SolarEdge Technologies...
October 19, 2023, 11:22 pm
Tourmaline bio announces closing of merger with talaris therapeutics and concurrent private placement of $75 million
Tourmaline will be focused on advancing TOUR006, its differentiated anti-IL-6 antibody, to treat thyroid eye disease (TED), atherosclerotic cardiovasc...
October 19, 2023, 9:37 pm
Allyx therapeutics to present phase 1 data for lead compound alx-001 at the 16th clinical trials on alzheimer’s disease meeting
Allyx’s lead compound, ALX-001, is a small molecule with unique mechanism of action at mGluR5, to protect and preserve synapses in neurodegenerative...
October 19, 2023, 8:05 pm
Ipo update: chromocell therapeutics seeks $8.7 million in micro-ipo
Chromocell Therapeutics Corporation has filed for an $8.7 million IPO to develop its treatment for chronic pain conditions. The company's lead compoun...
October 19, 2023, 5:31 pm
Intellia's (ntla) ind for gene-editing therapy gets fda clearance
Intellia (NTLA) gets FDA nod to begin a phase III study on its gene editing candidate, NTLA-2001 to tre...
October 19, 2023, 12:47 pm
Carlyle commodities reveals phase 2 drilling strategy at newton project in british columbia
Carlyle Commodities Corp (CSE:CCC, OTCQB:CCCFF) has outlined the phase 2 drilling strategy at its 100% ...
October 19, 2023, 9:04 am
Maia biotechnology to present preliminary safety and efficacy data from thio-101 phase 2 clinical trial at european society for medical oncology congress 2023
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology to Present Preliminary Safety and Efficacy Data from THIO-101 pha...
October 19, 2023, 8:35 am
Treasury yields surge, country garden wobbles, global markets on guard
Financial markets are once again immersed in a phase of risk aversion, a sentiment spurred by the notab...
October 19, 2023, 5:23 am
Gold price forecast: xau/usd’s further upside hinges on fed’s jerome powell
Gold price has entered a phase of bullish consolidation near $1,950, having reached an over two-month h...
October 19, 2023, 3:59 am
Calliditas therapeutics to present seven abstracts at the american society of nephrology (asn) kidney week 2023
STOCKHOLM , Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced seven ab...
October 19, 2023, 3:58 am
Sage therapeutics: several neuropsychiatric disorder data readouts in 2024
Sage Therapeutics, Inc. received FDA approval along with Biogen for its drug ZURZUVAE for the treatment of postpartum depression, with a planned launc...
October 18, 2023, 6:52 pm
Netflix boosts prices on some plans in us, uk & france
Netflix said today it's raising prices on some of its plans in the U.S., U.K and France with the Premium subscription Stateside now set at $22.99 a mo...
October 18, 2023, 4:32 pm
Hookipa pharma announces publication of preclinical data of hepatitis b virus (hbv) therapeutic vaccine developed in collaboration with gilead sciences
HB-400, a novel arenaviral therapeutic vaccine, generates robust T cell responses specific to hepatitis B virus with high antibody levels in a preclin...
October 18, 2023, 11:01 am
Why is viking therapeutics (vktx) stock moving today?
Viking Therapeutics (NASDAQ: VKTX ) stock is on the move Wednesday as the clinical-stage biopharmaceutical company reveals data from a clinical trial....
October 18, 2023, 10:01 am
Sage therapeutics jump 5% on huntington's drug call by fda
Shares of Sage Therapeutics Inc jumped 5% in premarket trading following the announcement that the US Food and Drug Administration (FDA) has granted...
October 18, 2023, 7:41 am
Viking therapeutics joins weight loss drug bandwagon as trial data impresses
Viking Therapeutics (NASDAQ:VKTX) shares shot up 12% in overnight US trading as the drug developer revealed more impressive trial data from a treatmen...
October 18, 2023, 7:06 am
Bitcoin price is about to see “liftoff” if it’s able to hold one crucial level
Bitcoin price is consolidating above the $28,000 support. BTC could gain bullish momentum if it clears the $28,550 resistance zone. Bitcoin started a ...
October 18, 2023, 3:31 am
Scancell to speak at prestigious vaccine event
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing immunotherapies for cancer and infectious disease, said its chief executive and chie...
October 18, 2023, 3:14 am
Cingulate to host cns key opinion leader panel in new york city
Expert Analysis of Cingulate, its phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform I...
October 17, 2023, 6:22 pm